144 related articles for article (PubMed ID: 21558090)
1. Glutathione S-transferase M1 polymorphism and bladder cancer risk: a meta-analysis involving 33 studies.
Jiang Z; Li C; Wang X
Exp Biol Med (Maywood); 2011 Jun; 236(6):723-8. PubMed ID: 21558090
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of glutathione S-transferase M1 and bladder cancer risk: a meta-analysis of 26 studies.
Zhang R; Xu G; Chen W; Zhang W
Mol Biol Rep; 2011 Apr; 38(4):2491-7. PubMed ID: 21082260
[TBL] [Abstract][Full Text] [Related]
3. GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis.
Yu C; Hequn C; Longfei L; Long W; Zhi C; Feng Z; Jinbo C; Chao L; Xiongbing Z
Oncotarget; 2017 Jan; 8(2):3246-3258. PubMed ID: 27911277
[TBL] [Abstract][Full Text] [Related]
4. Glutathione S-transferase M1 and T1 null genotypes and bladder cancer risk: A meta-analysis in a single ethnic group.
Chen DK; Huang WW; Li LJ; Pan QW; Bao WS
J Cancer Res Ther; 2018 Dec; 14(Supplement):S993-S997. PubMed ID: 30539835
[TBL] [Abstract][Full Text] [Related]
5. Glutathione S-transferase T1 polymorphism contributes to bladder cancer risk: a meta-analysis involving 50 studies.
Gong M; Dong W; An R
DNA Cell Biol; 2012 Jul; 31(7):1187-97. PubMed ID: 22339266
[TBL] [Abstract][Full Text] [Related]
6. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
7. Association of Glutathione S-transferase gene polymorphism with bladder Cancer susceptibility.
Zhou T; Li HY; Xie WJ; Zhong Z; Zhong H; Lin ZJ
BMC Cancer; 2018 Nov; 18(1):1088. PubMed ID: 30419877
[TBL] [Abstract][Full Text] [Related]
8. Glutathione S-transferase mu1 (GSTM1) status and bladder cancer risk: a meta-analysis.
Johns LE; Houlston RS
Mutagenesis; 2000 Sep; 15(5):399-404. PubMed ID: 10970445
[TBL] [Abstract][Full Text] [Related]
9. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review.
Engel LS; Taioli E; Pfeiffer R; Garcia-Closas M; Marcus PM; Lan Q; Boffetta P; Vineis P; Autrup H; Bell DA; Branch RA; Brockmöller J; Daly AK; Heckbert SR; Kalina I; Kang D; Katoh T; Lafuente A; Lin HJ; Romkes M; Taylor JA; Rothman N
Am J Epidemiol; 2002 Jul; 156(2):95-109. PubMed ID: 12117698
[TBL] [Abstract][Full Text] [Related]
10. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
[TBL] [Abstract][Full Text] [Related]
12. Glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null polymorphisms, smoking, and their interaction in oral cancer: a HuGE review and meta-analysis.
Zhang ZJ; Hao K; Shi R; Zhao G; Jiang GX; Song Y; Xu X; Ma J
Am J Epidemiol; 2011 Apr; 173(8):847-57. PubMed ID: 21436184
[TBL] [Abstract][Full Text] [Related]
13. Glutathione S-transferase M1 null genotype meta-analysis on gastric cancer risk.
Meng X; Liu Y; Liu B
Diagn Pathol; 2014 Jun; 9():122. PubMed ID: 24948179
[TBL] [Abstract][Full Text] [Related]
14. Association between glutathione S-transferase M1 null variant and risk of bladder cancer in Chinese Han population.
Xu W; Wang F; Ying L; Wang HH
Tumour Biol; 2014 Jan; 35(1):773-7. PubMed ID: 24022663
[TBL] [Abstract][Full Text] [Related]
15. Modifying Effect of Smoking on GSTM1 and NAT2 in Relation to the Risk of Bladder Cancer in Mongolian Population: A Case-Control Study.
Avirmed S; Khuanbai Y; Sanjaajamts A; Selenge B; Dagvadorj BU; Ohashi M
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2479-2485. PubMed ID: 34452561
[TBL] [Abstract][Full Text] [Related]
16. Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer.
Salinas-Sánchez AS; Sánchez-Sánchez F; Donate-Moreno MJ; Rubio-del-Campo A; Gimenez-Bachs JM; Lorenzo-Romero JG; Serrano-Oviedo L; Escribano J
BJU Int; 2011 Jun; 107(11):1825-32. PubMed ID: 20942828
[TBL] [Abstract][Full Text] [Related]
17. Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black and Asian smokers and nonsmokers.
Yu MC; Ross RK; Chan KK; Henderson BE; Skipper PL; Tannenbaum SR; Coetzee GA
Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):861-4. PubMed ID: 8634658
[TBL] [Abstract][Full Text] [Related]
18. GSTM1 Gene Polymorphism is Implicated in Increased Susceptibility to Prostate Cancer in Caucasians and Asians.
Wang ZY; Li HY; Jiang Z; Zhou TB; Drummen GP
Technol Cancer Res Treat; 2016 Dec; 15(6):NP69-NP78. PubMed ID: 26614779
[TBL] [Abstract][Full Text] [Related]
19. [Glutathione S-transferase M1 polymorphism and the risk on colorectal cancer: a multilevel meta regression].
He HQ; Chen K; Zhang Y; Tong F; Fan CH; Song L
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Dec; 26(12):992-4. PubMed ID: 16676598
[TBL] [Abstract][Full Text] [Related]
20. Glutathione S-transferase M1 gene polymorphism in bladder cancer patients. a marker for invasive bladder cancer?
Aktas D; Ozen H; Atsu N; Tekin A; Sozen S; Tuncbilek E
Cancer Genet Cytogenet; 2001 Feb; 125(1):1-4. PubMed ID: 11297759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
